Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR Therapeutics
Pharma
Vertex gains FDA expansion of Casgevy to those ages 2 and older
The FDA has granted a label expansion for children ages 2 and up to receive Vertex's gene therapy Casgevy for sickle cell disease or beta thalassemia.
Kevin Dunleavy
Jul 6, 2026 11:30am
Fierce Biotech
FDA reveals 2nd round of 'national priority' voucher winners
Nov 6, 2025 3:12pm
Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia
May 23, 2025 9:00am
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Breakthroughs Honorees
Sep 9, 2024 5:01am
Vertex files suit against US over access to fertility program
Jul 16, 2024 7:36am
